Stryker’s Organic Growth Impacted by Autumn Surges
The company's orthopedic business grew only 2% organically in 3Q21 due to the Delta variant and hospital staffing shortages. Nov 01, 2021
We've found 298 results
DePuy Synthes Expects Healthy Volume Recovery to End 2021
The company grew 0.5% in the third quarter of 2021 compared to the year prior as procedure declines peaked in July and August. Oct 20, 2021
IPO Landscape Favorable for Orthopedic Players
Three companies – Treace Medical Concepts, Bioventus and Paragon 28 – made the leap in 2021. Market conditions could induce more to go public in 2022. Oct 20, 2021
Episurf Developing MTP Joint Implant
The company targets the filing of an FDA 510(k) application for the Episealer MTP system late 2022 or first half of 2023. Sep 28, 2021
Royal Biologics Takes Diverse Approach to Autologous Live Cell Therapy
While autologous live cell therapies are not new, Royal Biologics is creating a unique value proposition through its growing ALC portfolio. Sep 22, 2021
Orthopedic Market Nears Normalization as 2021 Winds Down
The orthopedic market outperformed expectations in the first half of 2021, given gaps in vaccine coverage and the surging delta variant. Sep 08, 2021
LimaCorporate Delivers Strong Top-Line Performance in First Half
In 2Q21, the company regained much of its pre-pandemic growth momentum except for a lagging recovery in Italy. Aug 26, 2021
Medtronic Opens Fiscal Year With Spine Share Gains
The company's FY 1Q22 saw double-digit growth in its spine business, driven by strength in biologics and recovering surgical volumes. Aug 25, 2021
Executives Talk the Past, Present and Future of Robotics
Technology updates, the competitive landscape and surgeon and patient interest are pushing orthopedic companies to speed robotic iterations and innovations. Aug 18, 2021
What Orthopedic Executives Said About 2Q21
Second-quarter commentary from ortho executives focused on acquisitions, knee replacement sales performance and enabling technology’s impact. Aug 18, 2021
